US Physical TherapyUSPH +1.46%78 EPS without NRI is $2.60 as of Mar. 2026. GuruFocus rates USPH with a GF Score™ of 78/100 and a GF Value™ of $107.81 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 512 Healthcare Providers & Services companies, US Physical Therapy ranks worse than 66.02% on this metric.
US Physical Therapy's earnings per share without non-recurring items for the
three
months ended in Mar. 2026 was $0.46.
Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was $2.60.
During the past 12 months, US Physical Therapy's average earnings per share (NRI) Growth Rate was 2.00% per year.
During the past 3 years, the average earnings per share (NRI) Growth Rate was -0.90% per year.
During the past 5 years, the average earnings per share (NRI) Growth Rate was -6.30% per year.
During the past 10 years, the average earnings per share (NRI) Growth Rate was 2.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.
The historical rank and industry rank for US Physical Therapy's EPS without NRI or its related term are showing as below:
USPH'
s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -54.8 Med: 12.1 Max: 126.4
Current: -0.9
During the past 13 years, US Physical Therapy's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 126.40% per year. The lowest was -54.80% per year. And the median was 12.10% per year.
USPH's 3-Year EPS without NRI Growth Rate is ranked worse than 66.02% of 512
companies
in the Healthcare Providers & Services industry
Industry Median: 11
vs USPH: -0.90
US Physical Therapy's EPS (Basic) for the
three
months ended in Mar. 2026 was $-0.12.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was $0.50.
US Physical Therapy (NYSE:USPH) EPS without NRI Explanation
EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
US Physical Therapy EPS without NRI Related Terms
US Physical Therapy EPS without NRI Historical Data
* Premium members only.
The historical data trend for US Physical Therapy's EPS without NRI can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
USPH vs NUTX, PNTG, AMN: EPS without NRI Comparison
For the Medical Care Facilities subindustry, US Physical Therapy's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
US Physical Therapy PE Ratio without NRI vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, US Physical Therapy's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where US Physical Therapy's PE Ratio without NRI falls into.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.
EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.60
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
US Physical Therapy (USPH) has a EPS without NRI of $2.60 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on US Physical Therapy and its competitors. According to the industry distribution chart, US Physical Therapy ranks #338 out of 512 companies in the Healthcare Providers & Services industry, placing it in the top 66%.
Is US Physical Therapy's EPS without NRI too high?
US Physical Therapy's current EPS without NRI is $2.60. The Healthcare Providers & Services industry median EPS without NRI is 11.00. US Physical Therapy's value of $2.60 is 76.4% below this industry median. Based on the distribution chart, US Physical Therapy ranks #338 out of 512 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, US Physical Therapy has a GF Score™ of 78/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does US Physical Therapy's EPS without NRI compare to NUTX and PNTG?
According to the Healthcare Providers & Services industry distribution chart, US Physical Therapy ranks #338 out of 512 companies for EPS without NRI. This places US Physical Therapy in the lower half of its industry. The industry median EPS without NRI is 11.00. US Physical Therapy's value of $2.60 is 76.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Healthcare Providers & Services company?
The median EPS without NRI among Healthcare Providers & Services companies is 11.00, based on 512 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. US Physical Therapy's current EPS without NRI of $2.60 is 76.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on US Physical Therapy and its competitors. For the Healthcare Providers & Services industry, the median EPS without NRI is 11.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. US Physical Therapy's current EPS without NRI is $2.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is US Physical Therapy stock overvalued right now?
Based on GuruFocus' analysis, US Physical Therapy (USPH) is currently considered Significantly Undervalued. The stock's GF Value™ is $107.81, compared to a current price of $72.35 — trading 32.9% below its estimated fair value. The current EPS without NRI is $2.60 and 76.4% below the Healthcare Providers & Services industry median of 11.00. US Physical Therapy's overall GF Score™ is 78/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For US Physical Therapy (USPH), the current EPS without NRI is $2.60 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is US Physical Therapy (USPH) Overvalued in 2026?
Based on GuruFocus' analysis, US Physical Therapy stock appears to be undervalued.
The current stock price of $72.35 is trading 32.9% below its estimated GF Value™ of $107.81.
GuruFocus considers US Physical Therapy to be Significantly Undervalued.
Key valuation signals for USPH:
EPS without NRI: $2.60
GF Value™: $107.81 vs. price of $72.35 (32.9% below fair value)
Industry Position: 76.4% below the Healthcare Providers & Services median (#338 of 512)
No single metric tells the full story. See the USPH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
US Physical Therapy Inc through its subsidiaries operate outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal payment sources for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.
78GF Score
Get the complete analysis for USPH
EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
USPH has been successfully added to your 
